Theragnostic Target, Prostate-Specific Membrane Antigen—Also Specific for Nonprostatic Malignancies

This publication has 20 references indexed in Scilit:

• 586 Folate Hydrolase-1 is a novel target for J591-brachytherapy in Merkel cell carcinoma
  Journal of Investigative Dermatology, 2017
• Intra-individual comparison of 68Ga-PSMA-11-PET/CT and multi-parametric MR for imaging of primary prostate cancer
  European Journal of Nuclear Medicine and Molecular Imaging, 2016
• A Prospective Pilot Study of ⁸⁹ Zr-J591/Prostate Specific Membrane Antigen Positron Emission Tomography in Men with Localized Prostate Cancer Undergoing Radical Prostatectomy
  Journal of Urology, 2014
• High expression of prostate-specific membrane antigen in the tumor-associated neo-vasculature is associated with worse prognosis in squamous cell carcinoma of the oral cavity
  Laboratory Investigation, 2012
• Prostate-specific membrane antigen: a new potential prognostic marker of osteosarcoma
  Medical Oncology, 2011
• Prostate-Specific Membrane Antigen Expression Is a Potential Prognostic Marker in Endometrial Adenocarcinoma
  Cancer Epidemiology, Biomarkers & Prevention, 2008
• Prostate-specific membrane antigen expression as a predictor of prostate cancer progression
  Human Pathology, 2007
• Radioimmunotherapy of Prostate Cancer Using 90Y- and 177Lu-Labeled J591 Monoclonal Antibodies: Effect of Multiple Treatments on Myelotoxicity
  Clinical Cancer Research, 2005
• A dual-monoclonal sandwich assay for prostate-specific membrane antigen: Levels in tissues, seminal fluid and urine
  The Prostate, 2000
• Mapping, genomic organization and promoter analysis of the human prostate-specific membrane antigen gene
  Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, 1998